SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,671 | +28.0% | 583 | +21.0% | 0.00% | +100.0% |
| Q2 2023 | $55,199 | -9.2% | 482 | +9.3% | 0.00% | -50.0% |
| Q1 2023 | $60,783 | +22.2% | 441 | +14.8% | 0.00% | +100.0% |
| Q4 2022 | $49,759 | +18.5% | 384 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $42,000 | +50.0% | 376 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | -3.4% | 369 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -52.5% | 373 | -45.2% | 0.00% | -50.0% |
| Q4 2021 | $61,000 | -11.6% | 681 | -8.6% | 0.00% | 0.0% |
| Q3 2021 | $69,000 | +32.7% | 745 | +12.4% | 0.00% | 0.0% |
| Q2 2021 | $52,000 | +147.6% | 663 | +136.8% | 0.00% | +100.0% |
| Q1 2021 | $21,000 | +200.0% | 280 | +551.2% | 0.00% | – |
| Q4 2020 | $7,000 | +40.0% | 43 | +10.3% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 39 | +39.3% | 0.00% | – |
| Q2 2020 | $4,000 | +300.0% | 28 | +250.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 8 | +14.3% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 7 | +600.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |